A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

Published in:

2017

By:

• Shoji, Tadahiro;
• Takatori, Eriko;
• Omi, Hideo;
• Kagabu, Masahiro;
• Honda, Tatsuya;
• Futagami, Masayuki;
• Yokoyama, Yoshihito;
• Kaiho, Michiko;
• Tokunaga, Hideki;
• Otsuki, Takeo;
• Takano, Tadao;
• Yaegashi, Nobuo;
• Kojimahara, Takanobu;
• Ohta, Tsuyoshi;
• Nagase, Satoru;
• Soeda, Shu;
• Watanebe, Takafumi;
• Nishiyama, Hiroshi;
• Sugiyama, Toru

Publication type:

journal article